N4 Pharma Plc
N4P.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £1,728 | £626 | £1,205 | £1,027 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £118 | £135 | £69 | £176 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £0 | £15 | £0 | £11 |
| Total Curr. Assets | £1,846 | £776 | £1,274 | £1,214 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £0 |
| Goodwill | £0 | £0 | £61 | £61 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £0 | £0 | £61 | £61 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £1,846 | £776 | £1,335 | £1,275 |
| Liabilities | – | – | – | – |
| Payables | £0 | £23 | £12 | £20 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £78 | £101 | £44 | £62 |
| Total Curr. Liab. | £78 | £124 | £56 | £82 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £78 | £124 | £56 | £82 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £11,600 | £1,579 | £9,850 | £9,346 |
| Retained Earnings | -£24,756 | -£10,399 | -£23,655 | -£23,200 |
| AOCI | £186 | £115 | £114 | £107 |
| Other Equity | £14,737 | £9,468 | £14,941 | £14,874 |
| Total Equity | £1,767 | £648 | £1,250 | £1,128 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £1 | £4 | £29 | £66 |
| Total Liab. & Tot. Equity | £1,846 | £776 | £1,335 | £1,275 |
| Net Debt | -£1,728 | -£626 | -£1,205 | -£1,027 |